Back to CVE records
High 8.2Published Jul 21, 2026

CVE-2026-60674Vulnerability in the Oracle Business Intelligence Enterprise Edition product of Oracle Analytics (component: BI Platform Security).

Updated under an hour ago ()

Does this affect you?

It affects oracle business_intelligence. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Vulnerability in the Oracle Business Intelligence Enterprise Edition product of Oracle Analytics (component: BI Platform Security). Supported versions that are affected are 8.2.0.0.0 and 26.01.0.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Business Intelligence Enterprise Edition. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Business Intelligence Enterprise Edition accessible data as well as unauthorized update, insert or delete access to some of Oracle Business Intelligence Enterprise Edition accessible data. CVSS 3.1 Base Score 8.2 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N).

CVSS
8.2 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
Weakness (CWE)
CWE-284, CWE-306
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Aug 7, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
oracle business_intelligence
oracle:business_intelligence
8.2.0.0.0; 26.01.0.0.0
NVD

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.